C4 Therapeutics, Inc. (CCCC) Financial Statements

Comprehensive financial analysis for CCCC including key ratios, revenue trends, profitability metrics, and analyst recommendations. Get detailed CCCC financial performance analysis and investment insights.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio (TTM):N/A

Forward P/E:-1.29

EPS (TTM):$-1.48

Enterprise Value:$-185984.00

Profitability Ratios

Profit Margin:-259.60%

Return on Equity:-45.55%

Return on Assets:-20.29%

Operating Margin:-402.93%

Financial Health

Current Ratio:5.70

Quick Ratio:5.47

Debt to Equity:32.98

Beta (5Y):2.96

Revenue and Profit Trends

Growth Metrics

Revenue Growth

138.20%

Revenue Per Share

$0.57

Performance Metrics

Profit Margin Trend

-259.60%

Return on Equity

-45.55%

Return on Assets

-20.29%

Analyst Insights

Price Targets

Average Target

$15.80

High Target

$50.00

Low Target

$3.00

Analyst Recommendations

Analyst Coverage

5 Analysts

Upside Potential

+645.3%